Home › NDC Lookup › RxCUI directory › RxCUI 310248

Etoposide 20 MG/ML Injectable Solution — RxCUI 310248

Name: Etoposide 20 MG/ML Injectable Solution (RxCUI 310248)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 310248 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310248

Official nameEtoposide 20 MG/ML Injectable Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asVP-16 20 MG/ML Injectable Solution; etoposide (as etoposide phosphate) 20 MG/ML Injectable Solution

FDA products mapped15

Package NDCs mapped22

Reported Medicaid activity (SDUD)14,300 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Etoposide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Etoposide is a chemotherapy drug approved for two main cancers: small cell lung cancer and refractory testicular tumors — meaning testicular cancer that hasn't responded to other t...
What exactly is etoposide being used to treat in my case?
The most common things people experience are low blood counts — which means a higher risk of infection and bleeding — nausea, hair loss, fatigue, and appetite changes. Nausea is us...
What side effects should I actually expect?

📖 Read our full Etoposide guide →

🕸️ Concept Web — How Etoposide 20 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Etoposide 20 MG/ML Injectable Solution RxCUI 310248 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Etoposide 4179 IN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Avopef 2735798 BN
- Toposar 220347 BN
Dose forms 8

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Etoposide Injectable Solution 376890 SCDF
- Etoposide Injectable Product 1157928 SCDG
- Etoposide Injectable Solution [Avopef] 2735801 SBDF
- Etoposide Injectable Solution [Toposar] 362881 SBDF
- Avopef Injectable Product 2735800 SBDG
- Toposar Injectable Product 1178005 SBDG
- Injectable Solution 316949 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Etoposide 20 MG/ML 315912 SCDC
- Etoposide 20 MG/ML Injectable Solution [Avopef] 2735802 SBD
- Etoposide 20 MG/ML Injectable Solution [Toposar] 206831 SBD
- Etoposide 20 MG/ML [Avopef] 2735799 SBDC
- Etoposide 20 MG/ML [Toposar] 567639 SBDC

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Etoposide 20 MG/ML SCDC · 315912
Etoposide Injectable Solution SCDF · 376890
Etoposide Injectable Product SCDG · 1157928

Brand-Name Concepts

Etoposide 20 MG/ML Injectable Solution [Avopef] SBD · 2735802
Etoposide 20 MG/ML Injectable Solution [Toposar] SBD · 206831
Etoposide 20 MG/ML [Avopef] SBDC · 2735799
Etoposide 20 MG/ML [Toposar] SBDC · 567639
Etoposide Injectable Solution [Avopef] SBDF · 2735801
Etoposide Injectable Solution [Toposar] SBDF · 362881
Avopef Injectable Product SBDG · 2735800
Toposar Injectable Product SBDG · 1178005
Avopef BN · 2735798
Toposar BN · 220347

📦 FDA Products & Package NDCs

15 products · 22 package NDCs

22 package NDCs map to RxCUI 310248 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9376-01	1 VIAL in 1 BOX, UNIT-DOSE (0143-9376-01) / 5 mL in 1 VIAL	Etoposide	Hikma Pharmaceuticals USA Inc.	2019-10-01
00143-9510-01	1 VIAL in 1 BOX, UNIT-DOSE (0143-9510-01) / 5 mL in 1 VIAL	Etoposide	Hikma Pharmaceuticals USA Inc.	2017-10-23
00143-9511-01	1 VIAL in 1 BOX, UNIT-DOSE (0143-9511-01) / 25 mL in 1 VIAL	Etoposide	Hikma Pharmaceuticals USA Inc.	2017-10-23
00143-9512-01	1 VIAL in 1 BOX, UNIT-DOSE (0143-9512-01) / 50 mL in 1 VIAL	Etoposide	Hikma Pharmaceuticals USA Inc.	2017-10-23
16729-0114-08	1 VIAL, MULTI-DOSE in 1 BOX (16729-114-08) / 25 mL in 1 VIA...	Etoposide	Accord Healthcare Inc.	2015-03-03
16729-0114-11	1 VIAL, MULTI-DOSE in 1 BOX (16729-114-11) / 50 mL in 1 VIA...	Etoposide	Accord Healthcare Inc.	2015-03-03
16729-0114-31	1 VIAL, MULTI-DOSE in 1 BOX (16729-114-31) / 5 mL in 1 VIAL...	Etoposide	Accord Healthcare Inc.	2015-03-22
63323-0104-05	10 BOX in 1 CARTON (63323-104-05) / 1 VIAL, MULTI-DOSE in 1...	Etoposide	Fresenius Kabi USA, LLC	2001-07-18
63323-0104-06	1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-06) / 5 mL in 1 V...	Etoposide	Fresenius Kabi USA, LLC	2022-09-09
63323-0104-25	1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-25) / 25 mL in 1...	Etoposide	Fresenius Kabi USA, LLC	2001-07-18
63323-0104-50	1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-50) / 50 mL in 1...	Etoposide	Fresenius Kabi USA, LLC	2001-07-18
68001-0265-25	1 VIAL, MULTI-DOSE in 1 BOX (68001-265-25) / 5 mL in 1 VIAL...	Etoposide	BluePoint Laboratories	2013-11-14
68001-0265-26	1 VIAL, MULTI-DOSE in 1 BOX (68001-265-26) / 25 mL in 1 VIA...	Etoposide	BluePoint Laboratories	2013-11-14
68001-0265-27	1 VIAL, MULTI-DOSE in 1 BOX (68001-265-27) / 50 mL in 1 VIA...	Etoposide	BluePoint Laboratories	2013-11-14
68001-0681-25	1 VIAL, MULTI-DOSE in 1 CARTON (68001-681-25) / 5 mL in 1 V...	Etoposide	BluePoint Laboratories	2025-12-01
68001-0682-26	1 VIAL, MULTI-DOSE in 1 CARTON (68001-682-26) / 25 mL in 1...	Etoposide	BluePoint Laboratories	2025-12-01
68001-0683-27	1 VIAL, MULTI-DOSE in 1 CARTON (68001-683-27) / 50 mL in 1...	Etoposide	BluePoint Laboratories	2025-12-01
71288-0175-05	1 VIAL, MULTI-DOSE in 1 CARTON (71288-175-05) / 5 mL in 1 V...	Etoposide	Meitheal Pharmaceuticals Inc.	2025-02-01
71288-0176-25	1 VIAL, MULTI-DOSE in 1 CARTON (71288-176-25) / 25 mL in 1...	Etoposide	Meitheal Pharmaceuticals Inc.	2025-02-01
71288-0177-50	1 VIAL, MULTI-DOSE in 1 CARTON (71288-177-50) / 50 mL in 1...	Etoposide	Meitheal Pharmaceuticals Inc.	2025-02-01
83831-0144-05	1 VIAL in 1 CARTON (83831-144-05) / 5 mL in 1 VIAL	Avopef	Avyxa Pharma, LLC	2026-04-01
83831-0145-25	1 VIAL in 1 CARTON (83831-145-25) / 25 mL in 1 VIAL	Avopef	Avyxa Pharma, LLC	2026-06-24

Observed labelers: BluePoint Laboratories (6) · Fresenius Kabi USA, LLC (4) · Hikma Pharmaceuticals USA Inc. (4) · Accord Healthcare Inc. (3) · Meitheal Pharmaceuticals Inc. (3) · Avyxa Pharma, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9181	Etoposide injection	19	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.